Evidence map›Paper›PMID 41901237›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Evaluation of a Boron-Conjugated SRC Inhibitor Combined with Proton and X-Ray Irradiation in U-87 MG and U-87 MG IDH1

Cristiana Alberghina, Filippo Torrisi, Samuel Valable, Elsa Sarrazin, Isis Blanchard, Anthony Vela, Valentina Bravatà, Lorenzo Botta, Luca Lanzanò, Silvia Scalisi and 6 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Cristiana AlberghinaInstitute of Bioimaging and Complex Biological Systems, National Research Council, 90015 Cefalù, Italy.
Filippo TorrisiDepartment of Pharmaceutical and Health Sciences, University of Catania, 95123 Catania, Italy.ORCID 0000-0002-5820-9160
Samuel ValableISTCT UMR6030, CYCERON, University of Caen Normandy, CNRS, Normandy University, 14000 Caen, France.ORCID 0000-0003-0355-0270
Elsa SarrazinISTCT UMR6030, CYCERON, University of Caen Normandy, CNRS, Normandy University, 14000 Caen, France.
Isis BlanchardISTCT UMR6030, CYCERON, University of Caen Normandy, CNRS, Normandy University, 14000 Caen, France.
Anthony VelaDepartment of Medical Physics, Centre François Baclesse, 14000 Caen, France.
Valentina BravatàInstitute of Bioimaging and Complex Biological Systems, National Research Council, 90015 Cefalù, Italy.ORCID 0000-0001-9778-9252
Lorenzo BottaDepartment of Ecological and Biological Sciences, University of Tuscia, 01100 Viterbo, Italy.ORCID 0000-0002-0856-2986
Luca LanzanòDepartment of Physics and Astronomy «Ettore Majorana», University of Catania, 95123 Catania, Italy.ORCID 0000-0001-6539-394X
Silvia ScalisiDepartment of Physics and Astronomy «Ettore Majorana», University of Catania, 95123 Catania, Italy.
Maria P DemichelisDepartment of Physics «Alessandro Volta», University of Pavia, Via A. Bassi 6, 27100 Pavia, Italy.
Maria G SabiniNational Institute for Nuclear Physics (INFN), Laboratori Nazionali del Sud, 95123 Catania, Italy.
Iolanda V PattiNational Institute for Nuclear Physics (INFN), Laboratori Nazionali del Sud, 95123 Catania, Italy.
Giorgio RussoInstitute of Bioimaging and Complex Biological Systems, National Research Council, 90015 Cefalù, Italy.
Francesco P CammarataInstitute of Bioimaging and Complex Biological Systems, National Research Council, 90015 Cefalù, Italy.
Rosalba ParentiDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.ORCID 0000-0002-1614-4696

Funding

funding of research initiatives for technologies and innovative trajectories in the health and care sectors (Directorial Decree n. 931 of 06-06-2022)-project n. PNC0000003-AdvaNced Technologies for Human-centrEd Medicine (project acronym: ANTHEM) PNC0000003Piano di Incentivi per la Ricerca di Ateneo 2020-2022 - PIA.CE.RI. 2020-2022-Linea di intervento 3-Starting Grant MINDS 57722172163Research was also partially funded by Région Normandy RIN TREMPLIN CHOxTRaCC XXX
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA damageglioblastomaradiosensitivitytargeted therapy

Identifiers

PMID41901237
PMCPMC13028696

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.